M&A / Deals China’s Haisco forms immunology biotech with up to $1.5B from American VCs BioSpaceHaisco Pharmaceutical Group has been on a deal hot streak this year, inking major deals with Eli Lilly, AbbVie and more.Immunology & InflammationRead full story pharminent August 25, 2026 (Last updated: August 26, 2026) BioSpace Haisco Pharmaceutical Group has been on a deal hot streak this year, inking major deals with Eli Lilly, AbbVie and more. Immunology & Inflammation Read full story Post navigation Previous: Expanded US Imaavy approval first ever for wAIHANext: Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026